Medical devices, healthcare technology and the business of care
COMPANY INTELLIGENCE

Boston Scientific

Explore this company’s associated devices, FDA decisions and regulatory history.

Clinical monitoring equipment, editorial photography

Boston Scientific

Regulatory records
76
Linked recall entries
0
Headquarters
Not reported
COMPANY INTELLIGENCE

What the linked records show

MedtechLedger currently links 76 FDA records to the applicant name Boston Scientific. The collection includes 4 510(k) clearances. It includes 2 original PMA approvals. 30 entries are PMA supplements. 40 entries are 30-day notices. These are records held by this publication, rather than a count of the company’s entire portfolio.

The dated entries run from Aug 26, 1993 to Oct 3, 2026. Individual filings may concern different products or changes to an existing application; review the identifier and decision scope on each record.

Product code LWS appears in 33 of the 76 linked filings. The collection spans 8 FDA product codes and 9 original PMA application families. These figures describe the filings available here; they do not establish the company’s total device sales or market share.

The largest PMA family in this collection is P150012, with 23 linked entries. Follow the parent application and its dated supplements to distinguish the original device scope from later changes. 4 linked filings have a current plain-language explanation checked against the recorded FDA decision.

Applicant mailing address recorded by FDA: 4100 Hamline Ave. N, St Paul, MN, 55112. Recorded on P150012/S191, decision dated Oct 3, 2026.

Changes described in PMA records

P150012/S191: ESSENTIO MRI (Model L131); PROPONENT MRI (Model L231); ACCOLADE MRI (Model L331); ESSENTIO MRI (Models L110, L111); PRO

The FDA record P150012/S191 lists Boston Scientific as applicant for a 30-Day Notice supplement to PMA P150012, decided OK30 on 2026-10-03. The reported statement describes two manufacturing-related actions: implementing an additional acceptance activity for Accolade SL batteries and changing a specification for an existing Accolade EL battery specification. The device category is implantable pulse generator, pacemaker (non-CRT), product code LWP.

The action concerns battery acceptance and specification items, not a new approval of the whole system. The record does not identify which acceptance activity was added, what the revised EL specification is, or what validation data supported either change, so those details remain absent and the statement's purpose is not evidence of safety or clinical effectiveness.

FDA approval-order wording

to implement an additional acceptance activity for Accolade SL batteries and to change a specification for an existing Accolade EL battery specification

Oct 3, 2026 · 30-Day Notice

P910073/S193: ENDOTAK LEAD SYSTEM

FDA’s recorded scope: approval for supplemental labeling for the ENDOTAK RELIANCE ePTFE family of defibrillator leads to align with a July 2025 Product Advisory.

Sep 17, 2026 · Special (Immediate Track)

P960040/S515: Tachy Pulse Generators

FDA’s recorded scope: approval for the SMR16 software maintenance release to update the NG4 pulse generator firmware and Model 3868 Tachy programmer software application

Aug 25, 2026 · Real-Time Process

Subsidiaries and similarly named applicants can have separate records. The links below preserve the applicant and submission identifiers. Source records are linked on each filing.

Regulatory record history

Product / regulatory recordCompanyPathwayDecision dateSource
Boston ScientificPMA supplementOct 3, 2026FDA
Boston ScientificPMA supplementSep 17, 2026FDA
Boston Scientific510(k) clearanceSep 3, 2026FDA
Boston ScientificPMA supplementAug 25, 2026FDA
Boston Scientific510(k) clearanceAug 21, 2026FDA
Boston Scientific510(k) clearanceAug 12, 2026FDA
Boston ScientificPMA supplementJul 23, 2026FDA
Boston ScientificPMA supplementJul 23, 2026FDA
Boston ScientificPMA supplementJul 1, 2026FDA
Boston ScientificPMA supplementJul 1, 2026FDA
Boston ScientificPMA supplementJul 1, 2026FDA
Boston ScientificPMA supplementJun 9, 2026FDA
Boston ScientificPMA supplementJun 9, 2026FDA
Boston ScientificPMA supplementJun 3, 2026FDA
Boston ScientificPMA supplementJun 3, 2026FDA
Boston ScientificPMA supplementJun 3, 2026FDA
Boston ScientificPMA supplementJun 3, 2026FDA
Boston ScientificPMA supplementJun 3, 2026FDA
Boston ScientificPMA supplementJun 1, 2026FDA
Boston ScientificPMA supplementMay 19, 2026FDA
Boston ScientificPMA supplementMay 15, 2026FDA
Boston ScientificPMA supplementMay 15, 2026FDA
Boston ScientificPMA supplementMay 15, 2026FDA
Boston ScientificPMA supplementMay 15, 2026FDA
Boston ScientificPMA supplementMay 15, 2026FDA
Boston ScientificPMA supplementMay 15, 2026FDA
Boston ScientificPMA supplementMay 15, 2026FDA
Boston ScientificPMA supplementApr 22, 2026FDA
Boston ScientificPMA supplementApr 21, 2026FDA
Boston ScientificPMA supplementApr 10, 2026FDA
Boston ScientificPMA supplementApr 10, 2026FDA
Boston ScientificPMA supplementApr 10, 2026FDA
Boston ScientificPMA supplementApr 10, 2026FDA
Boston ScientificPMA supplementApr 10, 2026FDA
Boston ScientificPMA supplementApr 10, 2026FDA
Boston ScientificPMA supplementApr 10, 2026FDA
Boston Scientific510(k) clearanceApr 8, 2026FDA
Boston ScientificPMA supplementApr 1, 2026FDA
Boston ScientificPMA supplementMar 18, 2026FDA
Boston ScientificPMA supplementMar 6, 2026FDA
Boston ScientificPMA supplementMar 6, 2026FDA
Boston ScientificPMA supplementMar 6, 2026FDA
Boston ScientificPMA supplementFeb 20, 2026FDA
Boston ScientificPMA supplementFeb 20, 2026FDA
Boston ScientificPMA supplementFeb 20, 2026FDA
Boston ScientificPMA supplementFeb 13, 2026FDA
Boston ScientificPMA supplementFeb 13, 2026FDA
Boston ScientificPMA supplementJan 9, 2026FDA
Boston ScientificPMA supplementJan 8, 2026FDA
Boston ScientificPMA supplementJan 8, 2026FDA
Boston ScientificPMA supplementDec 19, 2025FDA
Boston ScientificPMA supplementDec 17, 2025FDA
Boston ScientificPMA supplementOct 24, 2025FDA
FINELINE II LeadsP960004/S109
Boston ScientificPMA supplementOct 24, 2025FDA
Boston ScientificPMA supplementOct 22, 2025FDA
Boston ScientificPMA supplementOct 22, 2025FDA
Boston ScientificPMA supplementOct 22, 2025FDA
Boston ScientificPMA supplementOct 17, 2025FDA
Boston ScientificPMA supplementSep 22, 2025FDA
Boston ScientificPMA supplementSep 22, 2025FDA
ACC SUP PLUGP910077/S196
Boston ScientificPMA supplementSep 16, 2025FDA
Boston ScientificPMA supplementSep 16, 2025FDA
ACC WRENCHP930035/S035
Boston ScientificPMA supplementSep 16, 2025FDA
ACC SUP VEIN PICKP830060/S091
Boston ScientificPMA supplementSep 16, 2025FDA
Boston ScientificPMA supplementSep 16, 2025FDA
Boston ScientificPMA supplementSep 16, 2025FDA
Boston ScientificPMA supplementSep 16, 2025FDA
Boston ScientificPMA supplementSep 16, 2025FDA
Boston ScientificPMA supplementAug 22, 2025FDA
Boston ScientificPMA supplementAug 22, 2025FDA
Boston ScientificPMA supplementAug 22, 2025FDA
Boston ScientificPMA supplementAug 19, 2025FDA
Boston ScientificPMA supplementAug 14, 2025FDA
Boston ScientificPMA supplementJul 28, 2025FDA
Boston ScientificPMA approvalApr 25, 2016FDA
Boston ScientificPMA approvalAug 26, 1993FDA
Source information

Source updated Nov 9, 2026. Retrieved Nov 20, 2026.